Buparlisib NSCLC - Search Videos

The Future of NSCLC Management | AJMC

The Future of NSCLC Management | AJMC

KRAS G12C-Mutated NSCLC: Current Treatment Paradigms | OncLive

KRAS G12C-Mutated NSCLC: Current Treatment Paradigms | OncLive

An Overview of NSCLC and Actionable Mutations | AJMC

An Overview of NSCLC and Actionable Mutations | AJMC

Lung Cancer Basics: Biomarkers in NSCLC & NCCN Guideline Review - Part 2

Lung Cancer Basics: Biomarkers in NSCLC & NCCN Guideline Review - Part 2

38 views7 months ago

Buparlisib and Chemotherapy Combination Lacks Overall Survival Benefit in PD-1-Treated Recurrent Head and Neck Cancer – Archyde

Buparlisib and Chemotherapy Combination Lacks Overall Survival Benefit in PD-1-Treated Recurrent Head and Neck Cancer – Archyde

WCLC 2025 Summary: Evolving Landscape of Treatment and Resistance to EGFR Inhibitors in NSCLC

WCLC 2025 Summary: Evolving Landscape of Treatment and Resistance to EGFR Inhibitors in NSCLC

ASCO 2024 Updates: Novel Approaches in NSCLC Therapy | OncLive

ASCO 2024 Updates: Novel Approaches in NSCLC Therapy | OncLive

Combination Therapy: A New Frontline Standard in the Treatment of EGFR-Mutant NSCLC | OncLive

Second-Line Metastatic NSCLC: Treatment Landscape and Challenges | OncLive

Marina Chiara Garassino, MD presents 5-year results from the EMPOWER-Lung 1 trial, discussing cemiplimab monotherapy's long-term survival benefits in advanced #NSCLC https://www.onclive.com/view/cemiplimab-monotherapy-for-first-line-advanced-nsclc-patients-with-pd-l1-expression-50-5-y-outcomes-of-empower-lung | OncLive

37 viewsJan 24, 2025

FacebookOncLive

HER2-Driven Strategies in Metastatic NSCLC

GSK is discontinuing cobolimab in NSCLC after mid-stage trial results. The antibody remains in the pipeline with ongoing studies in liver, cervical and skin cancers. Read our update on the trial and GSK’s next steps at https://buff.ly/fJOjJbx by Soumya Shashikumar. #GSK #Cobolimab #NSCLC #LungCancer #CancerResearch #OncologyPipeline #CancerTherapeutics #ImmunoOncology #CancerTreatment #LiverCancer #CervicalCancer | Xtalks Webinars

12 views8 months ago

FacebookXtalks Webinars

Comprehensive Molecular Testing in Early-Stage NSCLC: Best Practices and Multidisciplinary Strategies | OncLive

Application of guidelines-recommended broad molecular profiling to patients with NSCLC

Insights from COCOON: Prophylactic Dermatologic Management With Amivantamab Lazertinib in Advanced NSCLC | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways

targetedonc.com

Insights from global key opinion leaders on optimizing patient care in NSCLC

Guideline recommendations for first-line treatment of advanced NSCLC with targeted therapies

Emerging and practice-changing directions in NSCLC within the perioperative and locally advanced settings

Resectable Early-Stage NSCLC: How the Standard of Care Is Evolving | OncLive

Adlai Nortye Ltd. Announces Topline Results of Phase III Buran Trial Evaluating Buparlisib in Combination with Paclitaxel for Recurrent or Metastatic HNSCC

marketscreener.com

Dr. Konduri on Treatment Options for Patients With EGFR-Mutant NSCLC | OncLive

Guidelines-recommended targeted therapies as second-line treatment options for patients with metastatic NSCLC

Dr. Hamlin on Toxicities Associated With Ibrutinib and Buparlisib in MCL, FL, and DLBCL | OncLive

Expert Video Report on therapeutic advances in NSCLC from 2021 ASCO Annual Meeting

836 viewsJun 21, 2021

YouTubeEuropean Society for Medical Oncology (ESMO)

Neoadjuvant Nivolumab in Resectable Lung Cancer | NEJM

6.9K viewsMay 26, 2022

YouTubeNEJM Group

The Treatment Landscape For Advanced EGFR-Mutant NSCLC | Oncology Nursing News

oncnursingnews.com

Squamous Cell Carcinoma Treatment Options

33.7K viewsFeb 13, 2013

Pemetrexed for Advanced NSCLC

4.2K viewsJul 17, 2019

Immunotherapy for Lung Cancer

14.7K viewsJan 18, 2016

YouTubeGlobal Resource for Advancing Cancer Education

Video-Assisted Thoracoscopic Surgery

52.5K viewsFeb 26, 2018

YouTubeConexiant Content

See more